Agappe Diagnostics Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24239MH1998PLC115413 Incorporated 18 June 1998 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company healthcare
Data last updated
Revenue · FY 2025
₹520.96 Cr
▲ 17% YoY
Net profit · FY 2025
₹31.28 Cr
Net margin 6%
EBITDA · FY 2025
₹73.51 Cr
EBITDA margin 14.1%
Authorised capital
₹7 Cr
Registered with MCA
Paid-up capital
₹6.13 Cr
Issued & subscribed
Open charges
₹251.05 Cr
Satisfied ₹33.19 Cr
Company age
28 yrs
Est. 1998
Employees · EPFO
929
Provident fund records

About Agappe Diagnostics Limited

Data last updated:

Agappe Diagnostics Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 18 June 1998 and has been in existence for over 28 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1998PLC115413. Its GSTIN is 27AACCA3940Q1ZC (Maharashtra). The company holds 9 GST registrations, of which 8 are active.

The company has an authorised share capital of ₹7 Cr and a paid-up capital of ₹6.13 Cr. It was formerly known as Agappe Diagnostics Private Limited. It is led by directors including Thomas John (Managing Director) and Mary Baby Meleth (Whole-Time Director).

Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹520.96 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹31.28 Cr (net margin 6%) and EBITDA of ₹73.51 Cr (EBITDA margin 14.1%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 20% over five years.

The company has about 929 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Agappe. As per MCA filings, the company has open charges of ₹251.05 Cr and satisfied charges of ₹33.19 Cr on record. Court records list 235 cases involving the company, including 227 filed by the company and 8 filed against it; 51 cases are pending. The company has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹44.97 Cr; the latest was in March 2022. The company has 11 MSME Form 1 returns on record between 2017 and 2024, listing 355 overdue payments to 42 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website agappe.com.

Company details

CIN U24239MH1998PLC115413
Registration Number 115413
Incorporation Date 18 June 1998
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

CIN history

Agappe Diagnostics has one previous CIN (Corporate Identification Number): U24239MH1998PTC115413. The current CIN is U24239MH1998PLC115413, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239MH1998PLC115413Current
U24239MH1998PTC115413Previous

Contact details

Agappe Diagnostics Limited's registered office is in Mumbai, Maharashtra. Its website is agappe.com. Its e-mail address is in the company report.

  • Email
  • Website
  • Social Media
  • Apps
  • Registered Address
    602 Signature By Lotus Captain Suresh Sawant Marg, Off Veera Desai Road Andheri West, Mumbai, Maharashtra, India – 400053
  • Industry
    Healthcare, Medical & Laboratory Equipment

To see the full contact details of Agappe Diagnostics Limited, buy the company report.

Comprehensive company report
Agappe Diagnostics Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Agappe Diagnostics operates one associated brand: Agappe. Each brand links to its own profile.

BrandDescriptionWebsite
In-vitro diagnostic reagents and equipment are manufactured and distributed.agappe.com

Business activity

The main business activities of Agappe Diagnostics are manufacturing, trade and professional, scientific and technical. 4 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products
GTradeG1Wholesale Trading
CManufacturingC13Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities
MProfessional, Scientific and TechnicalM9Other professional, scientific and technical activities

To see the full business activity and turnover split of Agappe Diagnostics Limited, buy the company report.

Financials of Agappe Diagnostics Limited

FY 2025 filings available

Agappe Diagnostics Limited reported revenue of ₹520.96 Cr (up 17% YoY) for FY 2025.

Revenue · FY 2025
₹520.96 Cr ▲ 17%
Net profit · FY 2025
₹31.28 Cr margin 6%
EBITDA · FY 2025
₹73.51 Cr margin 14.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 6%
5 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▲ 65%
3 years · compounded
▼ 19%
5 years · compounded
▲ 26%

Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 17% growth in the latest year. EBITDA rose 65% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹73.51 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹31.28 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin14.1%
Net Profit Margin6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Agappe Diagnostics Limited, buy the company report.

Board of directors of Agappe Diagnostics Limited

Agappe Diagnostics has 9 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Mary Baby MelethWhole-Time Director01 Jan 20215 Years 10 MonthsCurrent
Rhema Elizabeth ThomasWhole-Time Director10 May 20215 Years 5 MonthsCurrent
Meena ThomasWhole-Time Director31 May 200719 Years 5 MonthsCurrent
Joseph JohnDirector26 Sep 20179 Years 1 MonthsCurrent
Thomas JohnManaging Director01 Jun 201214 Years 5 MonthsCurrent
Joseph Vadakkekara AntonyDirector30 Jun 20215 Years 4 MonthsCurrent
Showing 6 of 9 current directors. View all directors

Auditor

Agappe Diagnostics Limited is audited by B S R & Associates LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
B S R & Associates LLPFY 2023116231W/W-100024

Shareholding

The shareholding of Agappe Diagnostics Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Agappe Diagnostics Limited, buy the company report.

Charges & borrowings

Open charges
₹251.05 Cr
Satisfied charges
₹33.19 Cr
Breakdown by lending institutions
Axis Bank Limited₹106.05 Cr
Others₹103.00 Cr
State Bank of India₹42.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
03 Jul 2025101118059State Bank of India₹42 CrOpen
28 Mar 2024100902887Others₹88 CrOpen
23 Jan 2023100672938Others₹15 CrOpen
04 Aug 201210372923Axis Bank Limited₹106.05 CrOpen
16 Aug 201410517929The Federal Bank Ltd₹10.65 CrSatisfied

To see the full charge records of Agappe Diagnostics Limited, buy the company report.

Total charge records: 9 View all charges

Deals & funding

Agappe Diagnostics Limited has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹44.97 Cr; the latest was in March 2022.

Total deals
4
Funding rounds
2
Secondary share transfers
2
Disclosed funding
₹44.97 Cr

Deals on record (3 of 4)

WhenDealAmountParties
Mar 2022Secondary share transferUndisclosedBuyer: 2 individuals
Seller: an individual
Feb 2022Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Jan 2008Funding round₹1.47 CrInvestors: 4 individuals

To see the full deal history of Agappe Diagnostics Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Agappe Diagnostics Limited has 11 MSME Form 1 returns on record between 2017 and 2024, listing 355 overdue payments to 42 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 42)

SupplierAmount dueDue sinceReported on
Aaviza Electronics Private Limited
Abirami Electronics Private Limited
Glastronix LLP
DRF Technologies Private Limited
an individual supplier

To see the full MSME payment records of Agappe Diagnostics Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Agappe Diagnostics Limited has a workforce of 929 employees on its EPFO records as of Apr 10, 2024, across 2 active EPFO establishments.

Employee count
929
Active EPFO establishments
2
Employee growth
3.22%

GST

Agappe Diagnostics has 9 GST registrations: 8 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
9
Active
8
Cancelled / inactive
1
GSTINStateStatusRegistered on
27AACCA3940Q1ZCMaharashtraActive01 Jul 2017
09AACCA3940Q1ZAUttar PradeshActive01 Jul 2017
19AACCA3940Q1Z9West BengalActive01 Jul 2017
32AACCA3940Q1ZLKeralaActive01 Jul 2017

To see the full GST registrations and return filing status of Agappe Diagnostics Limited, buy the company report.

Recent activity

Agappe Diagnostics Limited has 27 board changes on record since 2006: 9 appointments and 18 cessations. The latest: Damodaran Madhavi Vasudevan was appointed as Whole-Time Director on 06 Jun 2023.

AGM
Agappe Diagnostics Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 88.00 Cr registered on 28 Mar 2024 with Charge ID 100902887 was modified on 16 Sep 2025.
Charges
A charge with State Bank Of India amounted to Rs. 42.00 Cr with Charge ID 101118059 was registered on 03 Jul 2025.
Filing
Agappe Diagnostics Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Axis Bank Limited of Rs. 106.05 Cr registered on 04 Aug 2012 with Charge ID 10372923 was modified on 17 Mar 2025.
Charges
A charge with Others amounted to Rs. 88.00 Cr with Charge ID 100902887 was registered on 28 Mar 2024.
Appointed
Damodaran Madhavi Vasudevan was appointed as Whole-Time Director.
Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 100672938 was registered on 23 Jan 2023.
Ceased
Thomas Jacob Kalappila ceased to be Additional Director.
Ceased
Ananth Narayan Gopalakrishnan ceased to be Director.
Appointed
Thomas Jacob Kalappila was appointed as Director.
Ceased
Yohannan Yoyakki Mechankara ceased to be Director.

35 earlier events are in the company report.

Frequently asked questions

Agappe Diagnostics is an active public limited company based in Mumbai, Maharashtra, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 18 June 1998 (28+ years old) and is registered under CIN U24239MH1998PLC115413.

Agappe Diagnostics has 9 current directors:

The latest financial statements of Agappe Diagnostics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Agappe Diagnostics is 27AACCA3940Q1ZC, registered in Maharashtra. The company has 9 GST registrations in all, of which 8 are active and 1 is cancelled or inactive. Other active GSTINs include 09AACCA3940Q1ZA (Uttar Pradesh), 19AACCA3940Q1Z9 (West Bengal), 32AACCA3940Q1ZL (Kerala).

The CIN (Corporate Identification Number) of Agappe Diagnostics is U24239MH1998PLC115413. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Agappe Diagnostics has 235 court cases on record: 227 filed by the company and 8 filed against it. 51 are pending. Most are in the district courts.

Agappe Diagnostics was incorporated on 18 June 1998, making it 28+ years old. It is registered with the Registrar of Companies, Mumbai.

Agappe Diagnostics has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹44.97 Cr; the latest was in March 2022.

Damodaran Madhavi Vasudevan was appointed as Whole-Time Director on 06 Jun 2023. Thomas Jacob Kalappila ceased to be Additional Director on 28 Apr 2022. Ananth Narayan Gopalakrishnan ceased to be Director on 18 Apr 2022. Agappe Diagnostics has 27 board changes on record in total.

Agappe Diagnostics has 11 MSME Form 1 returns on record between 2017 and 2024, listing 355 overdue payments to 42 micro and small suppliers. The latest return was filed on 26 Apr 2024.

Agappe Diagnostics can be reached through the website agappe.com. Its registered office is in Mumbai, Maharashtra, India.